Senior insider sale
VP of US Regulatory & FDA Rel. at TRANSMEDICS GROUP, INC. — senior position signals high conviction
$518.5K
6.58K shares
What this filing means
PROVOST MIRIAM plans to sell 6.58K shares of TRANSMEDICS GROUP, INC. valued at approximately $518.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/12/2024ACC: 0001972362-24-000406
Officer· VP of US Regulatory & FDA Rel.
Since May 2019
6.58K
Shares to sell
$518.5K
Approx. market value
1.81K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
STOCK OPTION EXERCISE
COMPENSATION
3/12/2024
1.81KTotal acquired1.81K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/12/2024 | STOCK OPTION EXERCISE COMPENSATION | 1.81K | — |
| Total | 1.81K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
647.00
Market value
$56.7K
3/8/2024
—Completed
Units to sell
4.12K
Market value
$309.5K
12/13/2023
Planned — Approximate Date
NASDAQPlanned
Units to sell
1.81K
Market value
$152.3K
3/12/2024
Total
Units
6.58K
Value
$518.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/8/2024 | 647.00 | $56.7K | — | Completed |
12/13/2023 | 4.12K | $309.5K | — | Completed |
| Planned — Approximate Date | ||||
3/12/2024 | 1.81K | $152.3K | NASDAQ | Planned |
| Total | 6.58K | $518.5K | ||